Detalles de la búsqueda
1.
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.
BJU Int
; 132(2): 188-195, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36855895
2.
The current recommendation for the management of isolated high-grade prostatic intraepithelial neoplasia.
BJU Int
; 129(5): 627-633, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34375498
3.
Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients.
J Biomed Sci
; 24(1): 81, 2017 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29058606
4.
Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.
Int J Mol Sci
; 15(8): 13615-23, 2014 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-25101846
5.
Reducing the demand for magnetic resonance imaging scans and prostate biopsies during the early detection of clinically significant prostate cancer: Applying the Barcelona risk-stratified pathway in Catalonia.
Urol Oncol
; 42(4): 115.e1-115.e7, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342654
6.
Metabolic syndrome increases the risk of aggressive prostate cancer detection.
BJU Int
; 111(7): 1031-6, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22883053
7.
Are magnetic resonance imaging and targeted biopsies needed in men with serum prostate-specific antigen over 10 ng/ml and an abnormal digital rectal examination?
Urol Oncol
; 41(7): 299-301, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37244767
8.
A Diagnostic Accuracy Study of Targeted and Systematic Biopsies to Detect Clinically Significant Prostate Cancer, including a Model for the Partial Omission of Systematic Biopsies.
Cancers (Basel)
; 15(18)2023 Sep 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37760511
9.
A Randomised Controlled Trial to Assess the Benefit of Posterior Rhabdosphincter Reconstruction in Early Urinary Continence Recovery after Robot-assisted Radical Prostatectomy.
Eur Urol Oncol
; 5(4): 460-463, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653674
10.
A Clinically Significant Prostate Cancer Predictive Model Using Digital Rectal Examination Prostate Volume Category to Stratify Initial Prostate Cancer Suspicion and Reduce Magnetic Resonance Imaging Demand.
Cancers (Basel)
; 14(20)2022 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36291883
11.
Who with suspected prostate cancer can benefit from Proclarix after multiparametric magnetic resonance imaging?
Int J Biol Markers
; 37(2): 218-223, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35200058
12.
Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category.
Eur Urol Open Sci
; 37: 38-44, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35243388
13.
The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer.
World J Mens Health
; 40(2): 270-279, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35021312
14.
Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer.
Cancers (Basel)
; 14(7)2022 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35406600
15.
Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy.
Cancers (Basel)
; 14(10)2022 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35625978
16.
The Barcelona Predictive Model of Clinically Significant Prostate Cancer.
Cancers (Basel)
; 14(6)2022 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35326740
17.
Prediction of clinically significant prostate cancer after negative prostate biopsy: The current value of microscopic findings.
Urol Oncol
; 39(7): 432.e11-432.e19, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33160846
18.
Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result.
Urol Oncol
; 38(5): 410-417, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32067845
19.
Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?
Eur Urol Oncol
; 2(6): 664-669, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31411977
20.
Behavior of SelectMDx and Prostate-specific Antigen Density in the Challenging Scenario of Prostate Imaging-Reporting and Data System Category 3 Lesions.
Eur Urol
; 81(1): 124-125, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34602313